Category Archives: BioUtah News
Recruitment for Non-Invasive Parkinson’s Pivotal Study Slated for December
Non-invasive Parkinson’s therapeutic device moves one step closer to FDA clearance, with important potential non-motor and motor improvements for patients. The maker of the widely anticipated Celeste® specialized phototherapy device, PhotoPharmics, today announced plans to begin recruitment for the Celeste Light for PD trial in December. “Multiple forces have aligned to make the timing for […]
nView s1 reaches its 100th surgery
The nView s1 has just surpassed its landmark 100th clinical case with the help of 22 surgeons at six leading pediatric facilities, including three of the top 10 facilities in the nation.
EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL
Edwards Lifesciences announced the launch of the SAPIEN 3 Ultra RESILIA valve, which incorporates Edwards’ breakthrough RESILIA tissue technology with the industry-leading SAPIEN 3 Ultra transcatheter aortic heart valve.
Inherent Biosciences raises Series A funding led by Propel Bio Partners to redefine the path to parenthood by elevating the standard of care in male reproductive health
Salt Lake City, Utah /PRNewswire/ — Inherent Biosciences, the first Utah company involved in commercializing a diagnostic in the emerging biotech field of epigenetics, has raised Series A funding from an investor group led by Los Angeles-based Propel Bio Partners toward Inherent’s goal of changing the course of reproductive health. Inherent seeks to redefine the […]
BIOHIVE STEM SEPTEMBER KICK-0FF
Last week, BioHive kicked off its celebration of “STEM September” with an evening of networking in downtown Salt Lake City. Life sciences professionals joined from all over the Salt Lake Valley to connect with the industry and support the efforts of BioHive. “I was so inspired hearing stories from the people that make Utah’s life […]
Rep. Burgess Owens Spends a Day in the BioHive
Utah life sciences companies took center stage September 2, as U.S. Representative Burgess Owens (R-UT) toured Canyon Labs, Ultradent (Canyon Labs’ parent company), Ortho Development and Xenter – all innovative leaders in advancing medical technologies that improve patient care and provide jobs for hundreds of Utahns. BioUtah helped to facilitate the BioHive day. “Utah is […]
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient
New Liquid Embolic Multi-Center Trial Successfully Enrolls Final Patient GPX® Trial Completes Enrollment Demonstrating Successful Tumor Uses and Other Applications Fluidx Medical announces completion of trial enrollment for its novel embolic device, GPX. In this multi-center trial, GPX was used to treat a variety of primary and metastatic tumors, renal adenoma tumors, and a range […]
Senator Mike Lee Spends a Day in the BioHive
U.S. Senator Mike Lee (R-UT) on August 15 spent the day connecting with Utah’s life sciences community, known as the BioHive, touring facilities at BD, IONIQ Sciences, SEEK Labs and Carterra. His schedule also included a tour of Altitude Lab in the University of Utah’s Research Park where he led a roundtable discussion with nearly […]
Halia Therapeutics Promotes Targeting the NLRP3 Inflammasome for Alzheimer’s Disease Treatment
Halia Therapeutics, the first biotechnology company to target NEK7 to block the assembly of the NLRP3 inflammasome complex, participated today in a fireside chat exploring approaches to innovate Alzheimer’s therapies at InformaConnect’s Therapeutic Focus-Neurology digital conference. “There is very little help available for people suffering from neuroinflammatory diseases, such as Alzheimer’s (AD). We do know […]
Renalytix Business Update
Based on recently secured private payer and Medicaid insurance coverage contracts for KidneyIntelX, Renalytix plc is disclosing that the upper Midwest region of the United States, and specifically Illinois and Iowa, are now primary commercial expansion markets. Private insurance coverage contracts secured and effective during the quarter ending September 30, 2022 include Blue Cross Blue […]
Nomi Health Adds Access to Novavax COVID Vaccine in Utah
Nomi Health, a direct healthcare company dedicated to improving access and lowering costs in the healthcare system, has expanded its COVID vaccine services with the addition of the Novavax vaccine, now available at the West Valley Nomi Health location. In addition to Novavax, this location also distributes Pfizer, Moderna and Johnson & Johnson vaccines. All […]
Additional Patent Protection For Exoskeleton Focal-Force Angioplasty Platform Granted by the U.S. Patent Office
Transit Scientific, a Utah-based medical device company, today announced additional U.S. patent protection has been issued from the United States Patent and Trademark Office (USPTO) for its XO exoskeleton sheath platform. Traditional PTA cutting, scoring, and constraining structure (CS) technologies are manufactured with metal or polymer wires, struts, blades, or grooves wrapped around, or fused to, the outside of the angioplasty balloon. These […]
